Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen

被引：0
|
作者：
Yukiko Onishi
Hitoshi Ishii
Tomonori Oura
Masakazu Takeuchi
机构：
[1] The Institute for Adult Diseases,Department of Diabetology
[2] Asahi Life Foundation,undefined
[3] Nara Medical University,undefined
[4] Eli Lilly Japan K.K.,undefined
[5] Medical Development Unit—Japan,undefined
来源：
Diabetes Therapy | 2020年 / 11卷
关键词：
Dulaglutide; Glycemic control; GLP-1 analog; Hypoglycemia; Insulin therapy; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：735 / 745
页数：10
相关论文
共 50 条
  • [41] Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes
    Tan, Xueying
    Cao, Xiaojing
    Zhou, Minzhi
    Zou, Ping
    Hu, Jingbo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (09) : 1083 - 1089
  • [42] Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks
    Diamant, Michaela
    Van Gaal, Luc
    Stranks, Stephen
    Guerci, Bruno
    MacConell, Leigh
    Haber, Harry
    Scism-Bacon, Jamie
    Trautmann, Michael
    DIABETES CARE, 2012, 35 (04) : 683 - 689
  • [43] Efficacy and Safety of Once-Weekly Insulin Regimes on Glycemic Control for Type 2 Diabetes: A Systematic Review and Network Meta-analysis
    Wang, Peng
    Zhang, Yu
    Xu, Wenhao
    He, Jialing
    Peng, Liyuan
    Feng, Yuning
    Xu, Ping
    Chong, Weelic
    Hai, Yang
    Jia, Lu
    Fang, Fang
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [44] Efficacy and Safety of Once-Weekly Insulin Regimes on Glycemic Control for Type 2 Diabetes: A Systematic Review and Network Meta-analysis
    Peng Wang
    Yu Zhang
    Wenhao Xu
    Jialing He
    Liyuan Peng
    Yuning Feng
    Ping Xu
    Weelic Chong
    Yang Hai
    Lu Jia
    Fang Fang
    Diabetology & Metabolic Syndrome, 16
  • [45] Efficacy and safety of switching to insulin icodec, a once-weekly basal insulin, vs insulin glargine U100 in patients with type 2 diabetes inadequately controlled on OADs and basal insulin
    Bajaj, H.
    Isendahl, J.
    Gowda, A.
    Stachlewska, K.
    Rosenstock, J.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S317 - S317
  • [46] COST UTILITY ANALYSIS OF ONCE-WEEKLY SEMAGLUTIDE AND DULAGLUTIDE FOR PATIENTS WITH TYPE 2 DIABETES IN SAUDI ARABIA
    Hassan, M.
    Barham, L.
    VALUE IN HEALTH, 2023, 26 (12) : S54 - S54
  • [47] Advances in Diabetes Treatment - Once-Weekly Insulin
    Gottlieb, Peter A.
    Michels, Aaron W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (22): : 2171 - 2172
  • [48] Once-weekly Insulin Icodec: An emerging treatment option for type 2 Diabetes
    Zahra, Rubab
    Tariq, Fasiha
    Ahmed, Mushood
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2024, 74 (08) : 1583 - 1583
  • [49] Efficacy and safety of once-weekly insulin icodec vs once-daily basal insulin in type 2 diabetes by ethnicity and race: ONWARDS 1-5
    Lingvay, I.
    Bangsgaard, K. O.
    Desouza, C.
    Fragao-Marques, M.
    Navarria, A.
    Vianna, A.
    DIABETOLOGIA, 2024, 67 : S375 - S376
  • [50] Impact of Age on the Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Insulin in Type 2 Diabetes (ONWARDS 1-5)
    Vianna, Andre G. D.
    Desouza, Cyrus
    Laugesen, Christian
    Marques, Mariana Fragao
    Nielsen, Pernille Hojlund
    Shaikh, Shehla S.
    Lingvay, Ildiko
    DIABETES, 2024, 73
12345